Welcome to CSNpharm! For Research Use Only!
Home +1-708-781-1677 sales@csnpharm.com    

DPP4

DPP4

Cat. No. Product Name CAS No. Information
CSN19749 ZY15557 1601480-12-9 ZY15557 is a potent competitive and long acting DPP-4 inhibitor showing similar DPP-4 inhibition across different species
CSN12287 Vildagliptin   274901-16-5 Vildagliptin is an inhibitor of DPP-4 with IC50 of 2.3 nM that is used in the treatment of type 2 diabetes mellitus.
CSN21260 Vildagliptin Dihydrate 2133364-01-7 Vildagliptin (LAF237 dihydrateNVP-LAF 237 dihydrate) is a dipeptidyl peptidase 4 (DPP4) inhibitor that delays the degradation of glucagon-like peptide-1 (GLP-1).
CSN16203 Trelagliptin Succinate   1029877-94-8 Trelagliptin succinate is an highly selective inhibitor of dipeptidyl peptidase-4 DPP-4 that is used for the treatment of type 2 diabetes
CSN16209 Trelagliptin 865759-25-7 Trelagliptin is a long acting dipeptidyl peptidase-4 DPP-4 inhibitor that is being developed for the treatment of type 2 diabetes T2D
CSN13813 Teneligliptin 760937-92-6 Teneligliptin is a potent and long-lasting dipeptidyl peptidase-4 inhibitor and competitively inhibits human plasma rat plasma and human recombinant DPP-4 in vitro with IC50 values of approximately 1 nM
CSN17332 Teneligliptin Hydrobromide   906093-29-6 Teneligliptin Hydrobromide is a DPP4 inhibitor with IC50 value of <1 nM. It is commonly used as an add on treatment when meformin is not achieving the expected glycemic goals.
CSN13509 Talabostat Mesylate 150080-09-4 Talabostat mesilate is an orally active specific inhibitor of dipeptidyl peptidases with IC50 of 1 nM for DPP4 including tumor-associated fibroblast activation protein
CSN21888 Talabostat 149682-77-9 Talabostat (Val-boroPro) is an orally active and nonselective dipeptidyl peptidase IV (DPP-IV) inhibitor with IC50 < 4 nM and the first clinical inhibitor of fibroblast activation protein (FAP) with IC50 of 560 nM) and also inhibits DPP8/9 (IC50 = 4/11 nM).
CSN10172 Sitagliptin Phosphate Monohydrate   654671-77-9 Sitagliptin Phosphate Monohydrate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts
CSN12755 Sitagliptin Phosphate   654671-78-0 Sitagliptin phosphate is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts
CSN17002 Sitagliptin 486460-32-6 Sitagliptin is a potent inhibitor of DPP4 with IC50 of 19 nM in Caco-2 cell extracts
CSN24704 Saxagliptin HCl   709031-78-7 Saxagliptin, also known as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. .
CSN13800 Saxagliptin Hydrate   945667-22-1 Saxagliptin the monohydrate form of anhydrous saxagliptin is a reversible and selective DPP4 inhibitor with IC50 of 26 nM It is used for the treatment of type 2 diabetes
CSN12346 Saxagliptin 361442-04-8 Saxagliptin is a selective and reversible DPP4 inhibitor with IC50 of 26 nM
CSN21399 Saikogenin A 5092-09-1 Saikogenin A, extracted from a Chinese herbal plant called Tsai-Fu, is a dipeptidyl peptidase-IV (DPP-IV) inhibitor.
CSN20590 Retagliptin Phosphate 1256756-88-3 Retagliptin phosphate is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes
CSN20588 Retagliptin 1174122-54-3 Retagliptin is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes
CSN20589 Retagliptin HCl 1174038-86-8 Retagliptin HCl is a DPP-4 inhibitor potentially used for the treatment of Type 2 diabetes.
CSN13845 Omarigliptin   1226781-44-7 Omarigliptin also called MA-3102 is an selective inhibitor of DPP-4 with IC50 of 16 nM and Ki of 08 nM Its selectivity is higher than other 168 proteasomes
CSN22003 Gosogliptin 869490-23-3 Metabolic Disease
CSN12323 Linagliptin   668270-12-0 Linagliptin a purine and quinazoline derivative can inhibit DPP-4 with IC50 of 1 nM It functions as an incretin and is used as a hypoglycemic agents in the treatment of type 2 diabetes mellitus
CSN20386 HBK001 1942922-78-2 HBK001 is a dual DPP4 inhibitor and GPR119 agonist that regulates glycemic control and beta cell function ex and in vivo
CSN20422 Gemigliptin 911637-19-9 Gemigliptin is an oral anti-hyperglycemic agent anti-diabetic drug of the dipeptidyl peptidase-4 DPP-4 inhibitor class of drugs
CSN20545 Evogliptin Tartrate 1222102-51-3 Evogliptin tartrate is a potent and selective DPP4 inhibitor dipeptidyl peptidase 4 inhibitor which improves insulin resistance and delays the onset of diabetes
CSN20543 Evogliptin 1222102-29-5 Evogliptin is a potent and selective DPP4 inhibitor dipeptidyl peptidase 4 inhibitor which improves insulin resistance and delays the onset of diabetes
CSN20544 Evogliptin HCl 1246960-27-9 Evogliptin HCl is a potent and selective DPP4 inhibitor (dipeptidyl peptidase 4 inhibitor) which improves insulin resistance and delays the onset of diabetes.
CSN17532 DBPR108 1186426-66-3 DBPR108 is a potent selective and orally bioavailable dipeptide-derived inhibitor of DPP4 with IC50 of 15 nM showing no inhibition on DDP8 and DPP9
CSN25468 Saxagliptin impurity F 361442-00-4 Boc-3-hydroxy-1-adamantyl-D-glycine is used in the preparation of a Saxagliptin intermediate.
CSN16158 Anagliptin 739366-20-2 Anagliptin is a potent and selective DPP-4 inhibitorIC50 38 nM and 10 fold less potent for DPP-8 and DPP-9
CSN10251 Alogliptin   850649-61-5 Alogliptin is a dipeptidyl peptidase 4 DPP-4 inhibitor with IC50 of 69 nM that exhibits greater selective than DPP-2 DPP-8 and DPP-9
CSN12318 Alogliptin Benzoate   850649-62-6 Alogliptin benzoate is the benzoate salt form of alogliptin which is a selective inhibitor of DPP-4 with IC50 of 69 nM that exhibits greater selective than DPP-2 DPP-8 and DPP-9
CSN13542 5-O-Demethylnobiletin 2174-59-6 5-O-Demethylnobiletin, a flavonoid isolated from the peel of Citrus nobilis Lour., shows a certain inhibitory effect on DPP-IV enzyme.
CSN25467 (2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetic acid 709031-29-8 3-Hydroxy-1-adamantyl-D-glycine is a non-proteinogenic amino acid , which is a key intermediate required for the synthesis of Saxagliptin (S143500).
<< PREV 1 2 NEXT >>